Page 53 - วารสารกรมการแพทย์แผนไทยฯ ปีที่ 11 ฉบับที่ 3
P. 53

262  «“√ “√°“√·æ∑¬å·ºπ‰∑¬·≈–°“√·æ∑¬å∑“߇≈◊Õ°         ªï∑’Ë 11 ©∫—∫∑’Ë 3°—𬓬π-∏—π«“§¡ 2556




             μ“√“ß∑’Ë 8 ƒ∑∏‘Ϭ—∫¬—È߇™◊ÈÕ‰«√— ‰¢âÀ«—¥„À≠à™π‘¥‡Õ (Flu A/H3) ¢Õß “√ °—¥πÈ”™π‘¥À¬“∫®“°·¡ß≈—°§“·≈– “√∫√‘ ÿ∑∏‘Ï

                                                  % plaque reduction μàÕ‡™◊ÈÕ‰¢âÀ«—¥„À≠à™π‘¥‡Õ∑’˧«“¡‡¢â¡¢âπ
                   μ—«Õ¬à“ß                                    (¡‘≈≈‘°√—¡/¡‘≈≈‘≈‘μ√)
                                                10          5        2.5       1.25      0.125

               “√ °—¥πÈ”™π‘¥À¬“∫®“°·¡ß≈—°§“    80.28      55.62       -          -         -
              3-(3,4-dihydroxyphenyl)lactic acid (1)  -   55.63     24.63        -         -
              rosmarinic acid (2)                -          -       76.81      40.94       -
              caffeic acid (3)                   -          -         -*        -*       34.78
             *‰¡à‰¥â∑¥ Õ∫‡π◊ËÕß®“°‡°‘¥§«“¡‡ªìπæ‘…μàÕ‡´≈≈宓°μ—«∑”≈–≈“¬ DMSO



             μ“√“ß∑’Ë 9 ƒ∑∏‘Ϭ—∫¬—È߇™◊ÈÕ‰«√— ‡Õ¥ å (HIV-1) ¢Õß “√ °—¥πÈ”™π‘¥À¬“∫®“°·¡ß≈—°§“·≈– “√∫√‘ ÿ∑∏‘Ï

                                                           √âÕ¬≈–¢Õß°“√¬—∫¬—Èß HIV-1 ∑’˧«“¡‡¢â¡¢âπ
                   μ—«Õ¬à“ß                                       (‰¡‚§√°√—¡/¡‘≈≈‘≈‘μ√)

                                                        100              25                6
               “√ °—¥πÈ”™π‘¥À¬“∫®“°·¡ß≈—°§“             >99             93.43             90
              3-(3,4-dihydroxyphenyl)lactic acid (1)    >99             98.56             90
              rosmarinic acid (2)                       >99              >99             96.87
              caffeic acid (3)                         96.87            34.37              0


                              «‘®“√≥å
                                                        ter ¢Õß 3-(3,4-dihydroxyphenyl)lactic acid (1)

                  ®“°º≈°“√·¬° “√ °—¥πÈ”™π‘¥À¬“∫®“° à«π  ·≈– caffeic acid (3) ®“°º≈°“√∑¥ Õ∫ƒ∑∏‘Ϭ—∫¬—Èß
             ‡Àπ◊Õ¥‘π·¡ß≈—°§“‡æ◊ËÕÀ“ “√∑’Ë¡’ƒ∑∏‘Ï∑“ß™’«¿“æμàÕ  ‡™◊ÈÕ‰«√— ‰¢âÀ«—¥„À≠à (FluA/H3) „πÀ≈Õ¥∑¥≈Õß
             ‰«√— ‰¢âÀ«—¥„À≠à™π‘¥‡Õ (Flu A/H3) ®π‰¥â “√  ¥â«¬‡∑§π‘§ plaque reduction æ∫«à“ “√∑—Èß “¡
             ∫√‘ ÿ∑∏‘ϥ⫬‡∑§π‘§ partition ·≈–§Õ≈—¡πå‚§√¡“  ™π‘¥¡’ƒ∑∏‘Ϭ—∫¬—È߇™◊ÈÕ‰«√— ‰¢âÀ«—¥„À≠à ‚¥¬ “√∫√‘ ÿ∑∏‘Ï

             ‚∑°√“øï·≈–°“√æ‘ Ÿ®πå Ÿμ√‚§√ß √â“ß∑“߇§¡’¥â«¬  1, 2 ·≈– 3 ∑’˧«“¡‡¢â¡¢âπ 5, 2.5 ·≈– 0.125
             ‡∑§π‘§ ‡ª°‚∑√ ‚§ªï ‡¡◊ËÕ‡ª√’¬∫‡∑’¬∫°—∫√“¬ß“π  ¡‘≈≈‘°√—¡/¡‘≈≈‘≈‘μ√  “¡“√∂¬—∫¬—È߇™◊ÈÕ‰¥â∑’Ë§à“‡©≈’ˬ
                    25-27
             °“√«‘®—¬   (√Ÿª∑’Ë 1, μ“√“ß∑’Ë 1-6) æ∫«à“·¬° “√  ‡∑à“°—∫ 55.63%, 76.81% ·≈– 34.78% μ“¡≈”¥—∫
             ‰¥â 3 ™π‘¥ ´÷Ë߇ªìπ “√°≈ÿà¡°√¥øïπÕ≈‘§ ‰¥â·°à 3-(3,4-  „π¢≥–∑’Ë “√ °—¥πÈ”™π‘¥À¬“∫®“°·¡ß≈—°§“ ∑’Ë
             dihydroxyphenyl)lactic acid (C H O ) (1),  §«“¡‡¢â¡¢âπ 5 ·≈– 10 ¡‘≈≈‘°√—¡/¡‘≈≈‘≈‘μ√
                                          9 10 5
             rosmarinic acid (C H O ) (2) ·≈– caffeic acid   “¡“√∂¬—∫¬—È߇™◊ÈÕ‰¥â∑’Ë§à“‡©≈’ˬ‡∑à“°—∫ 55.62% ·≈–
                             18 15 8
             [3-(3,4-dihydroxyphenyl)-propenoic acid]   80.28% μ“¡≈”¥—∫ ¥—ßπ—Èπ  “√∑’Ë¡’§«“¡·√ß„π°“√
             (C8H4O5) (3) ‚¥¬ rosmarinic acid (2) ‡ªìπ es-  ¬—∫¬—È߇™◊ÈÕ‰«√— ‰¢âÀ«—¥„À≠à (Flu A/H3) ®“°¡“°‰ª
   48   49   50   51   52   53   54   55   56   57   58